Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Inventory (2020 - 2025)

Biofrontera has reported Inventory over the past 6 years, most recently at $1.4 million for Q4 2025.

  • For Q4 2025, Inventory fell 78.54% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, down 78.54%, while the annual FY2025 figure was $1.4 million, 78.54% down from the prior year.
  • Inventory for Q4 2025 was $1.4 million at Biofrontera, down from $4.3 million in the prior quarter.
  • Over five years, Inventory peaked at $16.1 million in Q3 2023 and troughed at $1.4 million in Q4 2025.
  • A 5-year average of $6.9 million and a median of $6.5 million in 2025 define the central range for Inventory.
  • Biggest five-year swings in Inventory: soared 122.23% in 2022 and later plummeted 78.54% in 2025.
  • Year by year, Inventory stood at $4.5 million in 2021, then soared by 60.79% to $7.2 million in 2022, then surged by 52.18% to $10.9 million in 2023, then crashed by 39.07% to $6.6 million in 2024, then plummeted by 78.54% to $1.4 million in 2025.
  • Business Quant data shows Inventory for BFRI at $1.4 million in Q4 2025, $4.3 million in Q3 2025, and $4.0 million in Q2 2025.